Multiple roles of M-CSF in human osteoclastogenesis

Journal of Cellular Biochemistry

Volumn 102, Issue 3, 2007, Pages 759-768

  Hodge, Jason M ^a   Kirkland, Mark A ^a   Nicholson, Geoffrey C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone resorption; Cell fusion; CFU GM; Differentiation; M CSF; Osteoclastogenesis; Proliferation

Indexed keywords

COLONY STIMULATING FACTOR 1; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTIN; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

BONE RESORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOPLASM; FETAL BLOOD; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; OSTEOCLASTS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 35048832962     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21331     Document Type: Article

References (48)

1. Amano H, Yamada S, Felix R. 1998. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts. J Bone Miner Res 13:846-853.
2. Ash P, Loutit JF, Townsend KMS. 1980. Osteoclasts derived from haematopoietic stem cells. Nature 283:669-670.
3. Biskobing DM, Fan X, Rubin J. 1995. Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture. J Bone Miner Res 10:1025-1032.
4. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
5. Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13.
6. Denizot Y, Fixe P, Trimoreau F, Praloran V. 1996. Macrophage colony-stimulating factor levels in the plasma of bone marrow aspirate in several hematological malignancies. Stem Cells 14:363-365.
7. Edwards M, Sarma U, Flanagan AM. 1998. Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones. Bone 22:325-329.
8. Felix R, Cecchini MG, Fleisch H. 1990. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592-2594.
9. Fixe P, Denizot Y, Liozon E, Bordessoule D, Praloran V. 1995. Serum macrophage colony-stimulating factor concentrations in patients with lymphoid and non-lymphoid hematologic malignancies. Eur Cytokine Netw 6:217-218.
10. Fujikawa Y, Sabokbar A, Neale SD, Itonaga I, Torisu T, Athanasou NA. 2001. The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells. Bone 28:261-267.
11. Fuller K, Kirstein B, Chambers TJ. 2006. Murine osteoclast formation and function: Differential regulation by humoral agents. Endocrinology 147:1979-1985.
12. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ. 1993. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178:1733-1744.
13. Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Prontera C, Facchini V, Bianchi R, Genazzani AR. 1998. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer. Gynecol Oncol 70:111-114.
14. Gilbert HS, Praloran V, Stanley ER. 1989. Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: Association with myeloid metaplasia and peripheral bone marrow extension. Blood 74:1231-1234.
15. Gratzner HG. 1982. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218:474-475.
16. Hanamura T, Motoyoshi K, Yoshida K, Saito M, Miura Y, Kawashima T, Nishida M, Takaku F. 1988. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 72:886-892.
17. Hattersley G, Dorey E, Horton MA, Chambers TJ. 1988. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol 137:199-203.
18. Hattersley G, Owens J, Flanagan AM, Chambers TJ. 1991. Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun 177:526-531.
19. Hodge JM, Kirkland MA, Aitken CJ, Waugh CM, Myers DE, Lopez CM, Adams BE, Nicholson GC. 2004a. Osteoclastic potential of human CFU-GM: Biphasic effect of GM-CSF. J Bone Miner Res 19:190-199.
20. Hodge JM, Kirkland MA, Nicholson GC. 2004b. GM-CSF cannot substitute for M-CSF in human osteoclastogenesis. Biochem Biophys Res Commun 321:7-12.
21. Insogna KL, Sahni M, Grey AB, Tanaka S, Horne WC, Neff L, Mitnick M, Levy JB, Baron R. 1997. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 100:2476-2485.
22. Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. 1994. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J Hepatol 21:527-535.
23. Janowska-Wieczorek A, Belch AR, Jacobs A, Bowen D, Padua RA, Paietta E, Stanley ER. 1991. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood 77:1796-1803.
24. Katsumata N, Eguchi K, Fukuda M, Yamamoto N, Ohe Y, Oshita F, Tamura T, Shinkai T, Saijo N. 1996. Serum levels of cytokines in patients with untreated primary lung cancer. Clin Cancer Res 2:553-559.
25. Kawaji H, Yokomura K, Kikuchi K, Somoto Y, Shirai Y. 1995. Macrophage colony-stimulating factor in patients with rheumatoid arthritis. Nippon Ika Daigaku Zasshi 62:260-270.
26. Kodama H, Nose M, Niida S, Yamasaki A. 1991. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med 173:1291-1293.
27. Le Meur Y, Leprivey-Lorgeot V, Mons S, Jose M, Dantal J, Lemauff B, Aldigier JC, Leroux-Robert C, Praloran V. 2004. Serum levels of macrophage-colony stimulating factor (M-CSF): A marker of kidney allograft rejection. Nephrol Dial Transplant 19:1862-1865.
28. Matsui K, Yoshioka T, Murakami Y, Takahashi M, Shimada K, Ikeda U. 2003. Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease. Circ J 67:660-662.
29. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. 1998. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
30. Mroczko B, Szmitkowski M, Okulczyk B. 2003. Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med 41:646-651.
31. Nitta K, Akiba T, Kawashima A, Kimata N, Miwa N, Uchida K, Honda K, Takei T, Otsubo S, Yumura W, Kabaya T, Nihei H. 2001. Serum levels of macrophage colony-stimulating factor and aortic calcification in hemodialysis patients. Am J Nephrol 21:465-470.
32. Perkins SL, Kling SJ. 1995. Local concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation. Am J Physiol 269:E1024-E1030.
33. Scheven BAA, Visser JWM, Nijweide PJ. 1986. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321:79-81.
34. Scholl SM, Lidereau R, de la Rochefordiere A, Le-Nir CC, Mosseri V, Nogues C, Pouillart P, Stanley FR. 1996. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res Treat 39:275-283.
35. Seitz M, Loetscher P, Fey MF, Tobler A. 1994. Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol 33:613-619.
36. Smith JB, Bocchieri MH, Smith JB Jr, Sherbin-Allen L, Abruzzo JL. 1990. Colony stimulating factor occurs in both inflammatory and noninflammatory synovial fluids. Rheumatol Int 10:131-134.
37. Suehiro A, Imagawa T, Hosokawa H, Suehiro M, Ohe Y, Kakishita E. 1999. Age related elevation of serum macrophage colony stimulating factor (M-CSF) level. Arch Gerontol Geriatr 29:13-20.
38. Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I. 1998. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary. Gynecol Oncol 68:35-37.
39. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T. 1991. Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 6:977-985.
40. Takei I, Takagi M, Ida H, Ogino T, Santavirta S, Konttinen YT. 2000. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints. J Rheumatol 27:894-899.
41. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T. 1993. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257-263.
42. Teti A, Taranta A, Migliaccio S, Degiorgi A, Santandrea E, Villanova I, Faraggiana T, Chellaiah M, Hruska KA. 1998. Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene. J Bone Miner Res 13:50-58.
43. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. 1999. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand. Bone 25:517-523.
44. van Haaften-Day C, Shen Y, Xu F, Yu Y, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Bast RC Jr, Hacker NF. 2001. OVX1, macrophage-colony stimulating factor, and CA-125-11 as tumor markers for epithelial ovarian carcinoma: A critical appraisal. Cancer 92:2837-2844.
45. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER. 1990. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87:4828-4832.
46. Yao GQ, Wu JJ, Sun BH, Troiano N, Mitnick MA, Insogna K. 2003. The cell surface form of colony-stimulating factor-1 is biologically active in bone in vivo. Endocrinology 144:3677-3682.
47. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
48. Yoshida H, Hayashi S-I, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S-I. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.